6533b834fe1ef96bd129e20a
RESEARCH PRODUCT
Missense Mutations of Human Hsp60: A Computational Analysis to Unveil Their Pathological Significance
Alessandra Maria VitaleAlessandra Maria VitaleEverly Conway De MacarioEverly Conway De MacarioRiccardo AlessandroFrancesco CappelloFrancesco CappelloAlberto J. L. MacarioAlberto J. L. MacarioAntonella Marino GammazzaAntonella Marino Gammazzasubject
0301 basic medicineHsp60 gene variantlcsh:QH426-470chaperoning systemMutantunderdiagnosed chaperonopathiesDiseaseBiology03 medical and health sciences0302 clinical medicinehuman genomeGeneticsMissense mutationGeneGenetics (clinical)Hsp60 genetic chaperonopathieOriginal ResearchGeneticschemistry.chemical_classificationHsp60 genetic chaperonopathieshuman genomesHsp60 gene variantsAmino acidlcsh:Genetics030104 developmental biologychemistry030220 oncology & carcinogenesisMolecular MedicineHSP60Human genomeIdentification (biology)description
Two chaperonopathies have been linked to mutations in the human hsp60 (hHsp60; HSPD1) gene, but other existing variants might cause diseases, even if there is no comprehensive information about this possibility. To fill this vacuum, which might be at the basis of misdiagnoses or simply ignorance of chaperonopathies in patients who would benefit by proper identification of their ailments, we searched the sequenced human genomes available in public databases to determine the range of missense mutations in the single hsp60 gene. A total of 224 missense mutations were identified, including those already characterized. Detailed examination of these mutations was carried out to assess their possible impact on protein structure-function, considering: (a) the properties of individual amino acids; (b) the known functions of the amino acids in the human Hsp60 and/or in the highly similar bacterial ortholog GroEL; (c) the location of the mutant amino acids in the monomers and oligomers; and (d) structure-function relationships inferred from crystal structures. And we also applied a bioinformatics tool for predicting the impact of mutations on proteins. A portion of these genetic variants could have a deleterious impact on protein structure-function, but have not yet been associated with any pathology. Are these variants causing disease with mild clinical manifestations and are, therefore, being overlooked? Or are they causing overt disease, which is misdiagnosed? Our data indicate that more chaperonopathies might occur than is currently acknowledged and that awareness of chaperonopathies among medical personnel will increase their detection and improve patient management.
year | journal | country | edition | language |
---|---|---|---|---|
2020-08-01 | Frontiers in Genetics |